[1]
Boesjes, C.M. et al. 2022. Daily Practice Experience of Baricitinib Treatment for Patients with Difficult-to-Treat Atopic Dermatitis: Results from the BioDay Registry. Acta Dermato-Venereologica. 102, (Nov. 2022), adv00820. DOI:https://doi.org/10.2340/actadv.v102.3978.